Results 61 to 70 of about 56,978 (262)

Procaspase- 3 Status in Benign Prostatic Hyperplasia and Carcinoma (A Correlative Retrospective Study)

مجلة كلية الطب, 2009
Background: Benign prostatic hyperplasia and prostatic adenocarcinoma are two of the most common pathologic mass lesions. Both are encountered mainly in elderly males. The caspases family is a group of at least 15 known proteases that serve as initiator &
Alaa A. Qader, Nabeel W. Rasheed
doaj   +1 more source

Selenium biofortification: integrating one health and sustainability

Journal of the Science of Food and Agriculture, EarlyView.
Abstract Selenium (Se) biofortification in crops has emerged as a promising strategy to address global Se deficiencies and enhance both agricultural productivity and human health. Increasing the Se content of crops through biofortification improves their resilience to abiotic and biotic stresses and boosts their nutritional value.
Silvia Estarriaga‐Navarro, Nieves Goicoechea, Daniel Plano, Carmen Sanmartín   +3 more
wiley   +1 more source

Magnitude and factors associated with benign prostatic hyperplasia among adult male patients visiting Wolaita Sodo University comprehensive specialized hospital southern Ethiopia

Scientific Reports
Worldwide, in Africa and Ethiopia prevalence of Benign Prostatic Hyperplasia among patients with lower urinary tract symptoms was 26.2%, 44.2%, and 33.4% respectively.
Tirufat Tiruneh, Tamiru Getachew, Firdawek Getahun, Tesfaye Gebreyesus, Simeon Meskele   +4 more
doaj   +1 more source

Prostatic Artery Embolization as a New Option in the Treatment of Lower Urinary Tract Symptoms in Benign Prostatic Hyperplasia – Current Evidence

Acta Clinica Croatica, 2018
Prostatic artery embolization is a minimally invasive endovascular treatment that improves lower urinary tract symptoms in men with benign prostatic hyperplasia.
Luka Novosel, Ivan Pezelj, Igor Tomašković, Dijana Zadravec, Boris Ružić   +4 more
doaj   +1 more source

Nocturia and benign prostatic hyperplasia

Vojnosanitetski pregled, 2008
Background/Aim. Nocturia often occurs in patients with benign prostate hyperplasia (BPH). The aim of the study was to investigate the frequency of nocturia in patients with BPH. Nocturia and other factors associated with it were also investigated. Methods. Forty patients with the confirmed diagnosis of BPH were studied.
Vesna Laketic, Darko Laketic
openaire   +4 more sources

Widespread Skin Telangiectasias in Spinocerebellar Ataxia Type 27B

Annals of Neurology, EarlyView.
Victor Alm, Håkan Thonberg, Per Svenningsson, Martin Paucar   +3 more
wiley   +1 more source

The Evolving Landscape of Immunotoxicity: Charting Mechanisms and Future Strategies for Immune Checkpoint Inhibitor Adverse Events

Med Research, EarlyView.
ABSTRACT The use of immune checkpoint inhibitors (ICIs) has significantly improved the efficacy of cancer therapy, but their associated immune‐related adverse events (irAEs) can severely compromise treatment safety. This review systematically summarizes the core mechanisms underlying irAEs, which include multi‐organ damage resulting from T‐cell ...
Anqi Lin, Keyin Zheng, Aimin Jiang, Xufeng Huang, Qi Wang, András Hajdu, Zhengrui Li, Jian Zhang, Peng Luo   +8 more
wiley   +1 more source

Prostate blood flow in patients with benign prostatic hyperplasia complicated by urine retention

RUDN Journal of Medicine, 2012
Benign prostatic hyperplasia is the most frequent disease among middle and old aged men and connected with increasing of lifetime of men. The incidence of the disease is 42% to 87% in different aged groups.
E A Atamanova, V P Avdoshin, M I Andryukhin, V V Chugaev   +3 more
doaj  

Is It Necessary to Remove the Maximum Prostate Tissue in All Patients? the Percentage of Resected Prostate Tissue and the Influence on Surgery Outcomes: A One‐Year Follow Up Study

Neurourology and Urodynamics, EarlyView.
ABSTRACT Introduction To investigate whether the volume of the prostate tissue resected on TURP influences on short and medium term follow up. Methods It was developed a prospective study between May 2020 and August 2022, embracing patients with severe LUTS due to BPO, including clinical and urodynamic parameters meeting obstruction criteria (BOOI > 40)
Bruno Rodrigues Lebani, André Barcelos da Silva, Luciano Teixeira Silva, Marcia Eli Girotti, Eduardo Remaile Pinto, Milton Skaff, Fernando Gonçalves Almeida   +6 more
wiley   +1 more source

A giant prostatic hyperplasia treated by open surgery

International Journal of General Medicine, 2012
Soichiro Ogawa,1 Masahiko Manome,2 Michihiro Yabe,2 Yoshinobu Kuma,2 Masaaki Yamaoka,1 Yuichi Sato,1 Hidenori Akaihata,1 Toshiki Oguro,1 Masao Kataoka,1 Shin Kumagai,1 Yoshiyuki Kojima11Department of Urology, Fukushima Medical University, Fukushima ...
Ogawa S, Manome M, Yabe M, Kuma Y, Yamaoka M, Sato Y, Akaihata H, Oguro T, Kataoka M, Kumagai S, Kojima Y   +10 more
doaj